Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: Favorable response to intravenous immunoglobulins and prednisolone [1]

International Journal of Dermatology

Volumn 46, Issue 7, 2007, Pages 767-769

  Nanda, Mousumee ^a   Nanda, Arti ^a   Al Sabah, Humoud ^a   Dvorak, Richard ^a   Alsaleh, Qasem A ^a  

^a AL SABAH HOSPITAL   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; DESMOGLEIN 1; DESMOGLEIN 3; DOXORUBICIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PERIPLAKIN; PREDNISOLONE; VINCRISTINE;

ADULT; B CELL LEUKEMIA; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HEPATITIS C; HOSPITALIZATION; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LETTER; MALE; MULTIPLE CYCLE TREATMENT; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PHYSICAL EXAMINATION; SKIN BIOPSY; SYRIAN ARAB REPUBLIC;

DESMOGLEIN 3; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOCORTICOIDS; HEPATITIS C; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; PREDNISOLONE; SKIN;

EID: 34447273573     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03225.x     Document Type: Letter

References (14)

1. Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-1735.
2. Camisa C, Helm TN. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol 1993; 129: 883-886.
3. Joly P, Richard C, Gilbert D, et al. Sensitivity and specificity of clinical, histologic and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000; 43: 619-626.
4. Robinson MD, Hashimoto T, Amagi M, et al. The new pemphigus variants. J Am Acad Dermatol 1999; 40: 649-671.
5. Camisa C, Helm TN, Liu YC, et al. Paraneoplastic pemphigus: A report of three cases including one long-term survivor. J Am Acad Dermatol 1992; 27: 547-553.
6. Perniciaro C, Kuechle MK, Colon-Otero G, et al. Paraneoplastic pemphigus: A case of prolonged survival. Mayo Clin Proc 1994; 69: 851-855.
7. Nousari HC, Brodsky RA, Jones RJ, et al. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this therapy for severe autoimmune disease. J Am Acad Dermatol 1999; 40: 750-754.
8. Hertzberg MS, Schifter M, Sullivan J, et al. Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: Significant response to cyclophosphamide and prednisolone. Am J Hematol 2000; 63: 105-106.
9. Marzano A, Grammatica A, Cozzani E, et al. Paraneoplastic pemphigus. A report of two cases associated with chronic B-cell lymphocytic leukemia. Br J Dermatol 2001; 145: 127-131.
10. Gergely L, Varoczy L, Vadasz G, et al. Successful treatment of B-cell chronic lymphocytic leukemia associated severe paraneoplastic pemphigus with cyclosporine A. Acta Hematol 2003; 109: 202-205.
11. Schoen H, Foedinger D, Derfler K, et al. Immunopheresis in paraneoplastic pemphigus. Arch Dermatol 1998; 134: 706-710.
12. Van Rossum MM, Verhaegen NTM, Jonkman MF, et al. Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: Case report with review of novel treatment modalities. Leuk Lymphoma 2004; 45: 2327-2332.
13. Barnadas M, Roe E, Brunet S, et al. Therapy of paraneoplastic pemphigus with rituximab: A case report and review of literature. J Eur Acad Dermatol Venereol 2006; 20: 69-74.
14. Ahmed AR, Dahl MV. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering disease. Arch Dermatol 2003; 139: 1051-1059.